Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 57.4% | -53.4% | -71.9% |
| FY2022 | 58.9% | -27.3% | -31.3% |
| FY2023 | 64.9% | 16.0% | 12.7% |
| FY2024 | 54.5% | 7.3% | 5.5% |
| FY2025 | 48.8% | -10.4% | -12.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 57.4% | -53.4% | -71.9% |
| FY2022 | 58.9% | -27.3% | -31.3% |
| FY2023 | 64.9% | 16.0% | 12.7% |
| FY2024 | 54.5% | 7.3% | 5.5% |
| FY2025 | 48.8% | -10.4% | -12.5% |